CHST11, also known as Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 11 or Chondroitin 6-O-sulfotransferase 1 (C6ST-1), is a human gene that encodes an enzyme belonging to the sulfotransferase family. This enzyme plays a critical role in the biosynthesis of chondroitin sulfate, a major component of the extracellular matrix.
Function
The CHST11 enzyme is responsible for catalyzing the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the C-6 hydroxyl group of N-acetylgalactosamine (GalNAc) residues within chondroitin chains. This specific sulfation at the 6-position of GalNAc is crucial for determining the functional properties of chondroitin sulfate proteoglycans (CSPGs). The resulting chondroitin 6-sulfate motifs are vital for various biological processes.
Biological Roles
Chondroitin sulfate, modified by CHST11, is involved in a wide range of physiological functions, including:
- Extracellular Matrix Structure: It is a key component of cartilage, bone, and other connective tissues, providing structural integrity and resistance to compression.
- Cell Adhesion and Signaling: The sulfation patterns of chondroitin sulfate influence cell-cell and cell-matrix interactions, affecting cell adhesion, migration, and signaling pathways.
- Development: Critical for proper skeletal development, especially cartilage formation. It also plays a role in nervous system development, guiding axonal growth and neural plasticity.
- Inflammation and Immunity: Chondroitin sulfate interacts with various immune cells and molecules, modulating inflammatory responses.
Gene Location
The human CHST11 gene is located on chromosome 12, specifically at position 12q22.
Clinical Significance
Dysregulation or mutations in the CHST11 gene can lead to altered chondroitin sulfation patterns, which have been implicated in several pathologies:
- Skeletal Dysplasias: Impaired CHST11 function can result in skeletal abnormalities, including certain types of spondyloepiphyseal dysplasias, characterized by defects in cartilage and bone development.
- Cancer: Altered expression of CHST11 has been observed in various cancers, where changes in chondroitin sulfation can influence tumor cell growth, invasion, and metastasis.
- Inflammatory Diseases: Modifications in chondroitin sulfate mediated by CHST11 may contribute to the progression of inflammatory conditions.
Research into CHST11 continues to uncover its precise roles in health and disease, highlighting its importance in glycobiology and its potential as a therapeutic target.